-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SBBY66EoBN5KbVVCodi9g7UCT/YRGz5uYMJ4I/yTlaFdgUi4BiSBgy8oI8lo4H2I BKE5Wnr3MykOGofnbtaxCg== 0001209191-08-015482.txt : 20080304 0001209191-08-015482.hdr.sgml : 20080304 20080304155349 ACCESSION NUMBER: 0001209191-08-015482 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080229 FILED AS OF DATE: 20080304 DATE AS OF CHANGE: 20080304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oschmann Stefan CENTRAL INDEX KEY: 0001377189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 08663643 BUSINESS ADDRESS: BUSINESS PHONE: 908-423-1000 MAIL ADDRESS: STREET 1: MERCK & CO INC, ONE MERCK DRIVE STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084231688 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-02-29 0 0000064978 MERCK & CO INC (MRK) 0001377189 Oschmann Stefan ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 0 1 0 0 President, EMEA & Canada Common Stock 3333 D Common Stock - Dividend Reinvestment 13603.6743 D Employee Stock Option 2008/02/29 (right to buy) 44.30 2008-02-29 4 A 0 50000 0.00 A 2009-02-28 2018-02-28 Common Stock 50000 50000 D Restricted Stock Units 2008/02/29 2008-02-29 4 A 0 9375 0.00 A 2011-02-28 2011-02-28 Common Stock 9375 9375 D Holdings include shares acquired in dividend reinvestment transactions. The option vests in three equal annual installments beginning February 28, 2009. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Debra A. Bollwage as Attorney-in-Fact for Stefan Oschmann 2008-03-04 -----END PRIVACY-ENHANCED MESSAGE-----